These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 4338985)

  • 1. Stimulation of the medula oblongata of normal and hypertensive rats.
    Martínez Seeber A; Sallemi MI; Taquini AC
    Medicina (B Aires); 1972; 32(2):138-41. PubMed ID: 4338985
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulation of central cardiovascular centers in hypertension.
    Baum T; Shropshire AT
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):405-13. PubMed ID: 4326552
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for a role of AT(2) receptors at the CVLM in the cardiovascular changes induced by low-intensity physical activity in renovascular hypertensive rats.
    Rodrigues MC; Campagnole-Santos MJ; Machado RP; Silva ME; Rocha JL; Ferreira PM; Santos RA; Alzamora AC
    Peptides; 2007 Jul; 28(7):1375-82. PubMed ID: 17629353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
    Bayorh MH; Zukowska-Grojec Z; Kopin IJ; Feuerstein G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):85-90. PubMed ID: 6491978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of selective medullary coagulation on the cardiovascular response to intravenous infusion of angiotensin in the rabbit.
    Joy MD; Lewis PJ
    J Physiol; 1971 Oct; 218 Suppl(Suppl):70P-71P. PubMed ID: 4331827
    [No Abstract]   [Full Text] [Related]  

  • 6. AT1 receptor in rostral ventrolateral medulla mediating blunted baroreceptor reflex in spontaneously hypertensive rats.
    Gao XY; Zhang F; Han Y; Wang HJ; Zhang Y; Guo R; Zhu GQ
    Acta Pharmacol Sin; 2004 Nov; 25(11):1433-8. PubMed ID: 15525464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to nor-epinephrine, isoprenaline and spironolactone derivatives in normal and hypertensive rats.
    Eandi M; Ricci Gamalero S; Miocchi D
    Boll Soc Ital Biol Sper; 1979 Jul; 55(13):1252-8. PubMed ID: 508422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin II on arterial blood pressure, glomerular filtration rate and urinary sodium excretion in normal, pregnant and hypertensive rats.
    Kuczyńska-Sicińska J
    Pol Med J; 1972; 11(5):1113-24. PubMed ID: 4346231
    [No Abstract]   [Full Text] [Related]  

  • 9. Altered reflex vasodilatation in the hypertensive rat: possible role of histamine.
    Tobia AJ; Adams MD; Miya TS; Bousquet WF
    J Pharmacol Exp Ther; 1970 Dec; 175(3):619-26. PubMed ID: 4992408
    [No Abstract]   [Full Text] [Related]  

  • 10. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
    Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B
    J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonists of angiotensin. Effect on the blood pressure of normal and hypertensive rats.
    Saint-Louis J; Regoli D
    Rev Can Biol; 1972 Dec; 31(4):241-51. PubMed ID: 4350595
    [No Abstract]   [Full Text] [Related]  

  • 12. Central inhibitory noradrenergic cardiovascular control.
    de Jong W; Zandberg P; Bohus B
    Prog Brain Res; 1975; 42():285-98. PubMed ID: 1197726
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of the renin-system in normo- and hypertension. Effect of angiotensin-inhibitor (1-sar-8-ala-angiotensin II) on the blood pressure of conscious or anaesthetized normal, nephrectomized and renal hypertensive rats.
    Bing J; Nielsen K
    Acta Pathol Microbiol Scand A; 1973 May; 81(3):254-62. PubMed ID: 4358386
    [No Abstract]   [Full Text] [Related]  

  • 14. [Central A II-antagonism in experimental hypertension].
    Schölkens BA
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():240. PubMed ID: 565989
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
    Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T
    Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the vasopressor effect and inactivation of angiotensin in essential and renal as well as experimental hypertension].
    Wernze H; Hosoda S; Schölkens B
    Arch Klin Med; 1968; 214(3):286-305. PubMed ID: 4300861
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Failure to induce experimental hypertension in rats after intraventricular injection of 6-hydroxydopamine.
    Finch L; Haeusler G; Thoenen H
    Br J Pharmacol; 1972 Feb; 44(2):356P-357P. PubMed ID: 4148920
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of angiotensin II antagonists in experimental hypertension.
    Bumpus FM; Smeby RR; Sweet C; Ferrario CM; Khosla MC
    Circ Res; 1973 May; 32():Suppl 1:150-8. PubMed ID: 4351356
    [No Abstract]   [Full Text] [Related]  

  • 20. Involvement of the renin-angiotensin system in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats.
    Jochem J
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):39-55. PubMed ID: 15082866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.